Literature DB >> 2230841

Dexamethasone increases plasma levels of albendazole.

H Jung1, M Hurtado, M T Medina, M Sanchez, J Sotelo.   

Abstract

Therapy of neurocysticercosis with cysticidal drugs is frequently complicated by the exacerbation of symptoms that follows the inflammation triggered by the acute destruction of cysticerci. Treatment of such adverse reactions with dexamethasone is highly effective. However, it has been shown that dexamethasone lowers the plasma levels of praziquantel, thus reducing its cysticidal efficacy. We measured plasma levels of albendazole, another strong cysticidal drug, when dexamethasone was given simultaneously. We found that dexamethasone increased the plasma levels of albendazole by about 50% (P less than 0.002); hence, it seems that cysticercosis and the ensuing inflammation can be treated simultaneously with albendazole and dexamethasone without diminishing the efficacy of the cysticidal drug.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2230841     DOI: 10.1007/bf00314741

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  10 in total

1.  Neurocysticercosis. Short course of treatment with albendazole.

Authors:  F Alarcón; L Escalante; G Dueñas; M Montalvo; M Román
Journal:  Arch Neurol       Date:  1989-11

2.  Sensitive high-performance liquid chromatographic assay for albendazole and its main metabolite albendazole sulphoxide in plasma and cerebrospinal fluid.

Authors:  M Hurtado; M T Medina; J Sotelo; H Jung
Journal:  J Chromatogr       Date:  1989-09-29

3.  Praziquantel for neurocysticercosis.

Authors:  J Sotelo
Journal:  Lancet       Date:  1989-04-22       Impact factor: 79.321

Review 4.  Treatment of neurocysticercosis: is praziquantel the new hope?

Authors:  M Moodley; A Moosa
Journal:  Lancet       Date:  1989-02-04       Impact factor: 79.321

5.  Praziquantel and dexamethasone.

Authors:  F Alarcón; Y Pérez; H Banda
Journal:  Neurology       Date:  1988-06       Impact factor: 9.910

6.  Comparison of therapeutic regimen of anticysticercal drugs for parenchymal brain cysticercosis.

Authors:  J Sotelo; O H del Brutto; P Penagos; F Escobedo; B Torres; J Rodriguez-Carbajal; F Rubio-Donnadieu
Journal:  J Neurol       Date:  1990-04       Impact factor: 4.849

Review 7.  Neurocysticercosis in the United States: 35 cases and a review.

Authors:  M P Earnest; L B Reller; C M Filley; A J Grek
Journal:  Rev Infect Dis       Date:  1987 Sep-Oct

8.  Plasma and CSF levels of albendazole and praziquantel in patients with neurocysticercosis.

Authors:  H Jung; M Hurtado; M Sanchez; M T Medina; J Sotelo
Journal:  Clin Neuropharmacol       Date:  1990-12       Impact factor: 1.592

9.  Plasma levels of praziquantel decrease when dexamethasone is given simultaneously.

Authors:  M L Vazquez; H Jung; J Sotelo
Journal:  Neurology       Date:  1987-09       Impact factor: 9.910

10.  Therapy of parenchymal brain cysticercosis with praziquantel.

Authors:  J Sotelo; F Escobedo; J Rodriguez-Carbajal; B Torres; F Rubio-Donnadieu
Journal:  N Engl J Med       Date:  1984-04-19       Impact factor: 91.245

  10 in total
  29 in total

Review 1.  Bone hydatid disease.

Authors:  X H Song; L W Ding; H Wen
Journal:  Postgrad Med J       Date:  2007-08       Impact factor: 2.401

2.  Pharmacokinetic study of praziquantel administered alone and in combination with cimetidine in a single-day therapeutic regimen.

Authors:  H Jung; R Medina; N Castro; T Corona; J Sotelo
Journal:  Antimicrob Agents Chemother       Date:  1997-06       Impact factor: 5.191

Review 3.  Pediatric spinal infections-a review of non-tuberculous infections.

Authors:  Chandan B Mohanty; Graham Fieggen; Chandrashekhar E Deopujari
Journal:  Childs Nerv Syst       Date:  2018-07-03       Impact factor: 1.475

Review 4.  Cerebral Toxocariasis: Silent Progression to Neurodegenerative Disorders?

Authors:  Chia-Kwung Fan; Celia V Holland; Karen Loxton; Ursula Barghouth
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

5.  NEUROLOGICAL INFECTIONS IN THE RETURNING INTERNATIONAL TRAVELER.

Authors:  May H Han; Melanie Walker; Joseph R Zunt
Journal:  Continuum (Minneap Minn)       Date:  2006-04

6.  Concentrations of albendazole in serum, cerebrospinal fluid and hydatidous brain cyst.

Authors:  D Moskopp; E Lotterer
Journal:  Neurosurg Rev       Date:  1993       Impact factor: 3.042

Review 7.  Clinical aspects of eosinophilic meningitis and meningoencephalitis caused by Angiostrongylus cantonensis, the rat lungworm.

Authors:  Gerald S Murphy; Stuart Johnson
Journal:  Hawaii J Med Public Health       Date:  2013-06

8.  Enantioselective distribution of albendazole metabolites in cerebrospinal fluid of patients with neurocysticercosis.

Authors:  O M Takayanagui; P S Bonato; S A C Dreossi; V L Lanchote
Journal:  Br J Clin Pharmacol       Date:  2002-08       Impact factor: 4.335

9.  Neurocysticercosis with a single brain lesion in Germany: a case report.

Authors:  Felix Luessi; Janina Sollors; Katrin Frauenknecht; Eike Schwandt; Harald D Mueller; Peter Stoeter; Johannes Blum; Frank Thoemke
Journal:  Cases J       Date:  2009-09-09

10.  Multilevel intramedullary spinal neurocysticercosis with eosinophilic meningitis.

Authors:  Amir M Torabi; Mary Quiceno; Dianne B Mendelsohn; Craig M Powell
Journal:  Arch Neurol       Date:  2004-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.